The global tumour necrosis factor (TNF) inhibitor drugs market reached approximately USD 41.16 Billion in 2024. Despite its maturity, the market is expected to maintain steady growth at a CAGR of 0.70% from 2025 to 2034, reaching around USD 44.13 Billion by 2034. This growth is supported by the continued demand for effective therapies in managing autoimmune conditions such as rheumato... https://www.expertmarketresearch.com/reports/tumor-necrosis-factor-inhibitor-drugs-market